GE Healthcare Announces European Union Approval of VIZAMYL™ (Flutemetamol (18F) solution for injection) for PET Imaging of Beta Amyloid Plaque in Suspected Alzheimer’s Disease
PET Imaging Agent Receives Marketing Authorisation from the European Commission Chalfont St. Giles, UK — 1st September, 2014 — GE Healthcare announced today that VIZAMYL™ (flutemetamol (18F) solution for injection) has received marketing authorisation from the European Commission as a radiopharmaceutical medicinal product indicated for Positron Emission Tomography (PET) imaging of beta amyloid neuritic plaque […]